Canada Wants Tamiflu Patients Alert To Abnormal Behavior
This article was originally published in The Pink Sheet Daily
Executive Summary
Health Canada has asked Roche to update prescribing information for the influenza antiviral; move follows addition of precautions to the U.S. label.